Question 111 marks
Question
(a) Antibody molecules are proteins that show primary structure, secondary structure, tertiary structure and quaternary structure. Fig. 1.1 shows a ribbon diagram of an antibody molecule. Fig. 1.1 Describe how Fig. 1.1 shows the secondary structure and tertiary structure of the antibody molecule. secondary structure …… tertiary structure …… [3] (b) Fig. 1.2 is a transmission electron micrograph of a hybridoma cell. X Y Fig. 1.2 (i) The hybridoma cell in Fig. 1.2 synthesises and secretes molecules of a monoclonal antibody. State the roles of the structures labelled X and Y in the production of antibody molecules in the hybridoma cell. X …… Y …… [2] (ii) The hybridoma method for the production of monoclonal antibodies involves a number of stages. One of these stages is the formation of hybridoma cells. Outline the stage in which hybridoma cells are formed. …… [3] (iii) Outline the use of monoclonal antibodies in the treatment of disease. …… [3] [Total: 11]
Mark scheme
1(a) any three from: 3 secondary structure I α-helix 1 (many) β-pleated / beta-pleated, sheets ; R ‘B’ 2 random structure / irregular structures / loops / beta turns / AW ; tertiary structure 3 folding / coiling, of, (each) polypeptide chain(s) / secondary structure ; R idea of polypeptide chains interacting (quaternary structure) 4 ref. to globular A description, e.g. spherical I circular / round or ref. to 3D, shape / structure ; A 3D arrangement 1(b)(i) X – site of synthesis of, (light and heavy) polypeptides ; A protein(s) 2 A transport / modification, of, polypeptides / proteins A assembly of polypeptides / translation R answers that name the Golgi body Y – production of ATP ; R ‘produce / create / AW, energy’ A release of energy / provide energy 1(b)(ii) cell / membrane, fusion / AW ; I ‘mix’ 3 (named) fusogen / hybridogen used ; e.g. polyethylene glycol / electrofusion / electric current A PEG for polyethylene glycol (between) plasma cell / (activated) B-lymphocyte / (activated) B-cell / splenocyte, and, tumour / cancer / myeloma, cell ; R β cells 1(b)(iii) any three from: 3 1 some mAbs act directly on target cells / some mAbs work indirectly to kill cells / mAbs do not damage other (non- target) cells ; 2 by binding to, specific / complementary, antigens/cell surface receptors ; 3 (named), drugs / radioactive isotopes, can be attached to mAbs ; A ‘tagged’ I labelled 4 enzymes can be attached to mAbs ; 5 so drug can be activated at site of action (linked to mp4) ; 6 bispecific mAbs attach two cells together ; 7 ref. to interrupting cell signalling ; 8 use of mAbs for passive immunity ; A described in context of therapeutic antibody for treatment of disease 9 stimulating / AW, immune system / phagocytes / macrophages / T-lymphocyes, to kill, cancer cells ; 10 name of a cancer or autoimmune disease that is treated with mAbs ;